Hepatitis C Ribonucleic Acid (RNA) Testing Before Initiating Treatment
INACTIVE REVIEW: This measure review is older than five years.
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom quantitative HCV RNA testing was performed within 6 months prior to initiation of antiviral treatment (paired with NQF 0396)
ACP does not support NQF 0395: “Hepatitis C Ribonucleic Acid (RNA) Testing Before Initiating Treatment.” Although this practice represents the standard of care, the evidence presented in support of the measure shows a very small gap in care (about 10%), which could be explained by error in data collection. The small potential benefit is outweighed by the burden of measurement.